Read more here: Arbutus Announces Presentation of Phase 1a/1b Clinical Trial Results for AB-729 in Chronic Hepatitis B Subjects at The Liver Meeting Digital...
Read more here: Arbutus Announces Presentation of Phase 1a/1b Clinical Trial Results for AB-729 in Chronic Hepatitis B Subjects at The Liver Meeting Digital...
Original post: RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
Read more here: Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent
Read more: Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
Read the original here: BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator
Read more: ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor
Read the original here: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the eleventh time
Read more from the original source: AB Science secures equity financing for a maximum of 4 million shares with Alpha Blue Ocean’s PACT
Read more: Genenta’s Temferon™: Evidence of Controlled and Targeted Interferon Expression in Preliminary Phase I/II Clinical Data in Glioblastoma Multiforme
Read more: Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.
Recent Comments